Efficacy of low-dose interferon α2a 18 versus 60 months of treatment in patients with primary melanoma of ≥ 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial
by Hauschild, Axel (Author)
, Weichenthal, Michael (Author)
, Rass, Knuth (Author)
, Linse, Ruthild (Author)
, Berking, Carola (Author)
, Böttjer, Jörg (Author)
, Vogt, Thomas (Author)
, Spieth, Konstanze (Author)
, Eigentler, Thomas (Author)
, Brockmeyer, Norbert (Author)
, Stein, Annette (Author)
, Näher, Helmut (Author)
, Schadendorf, Dirk (Author)
, Mohr, Peter (Author)
, Kaatz, Martin (Author)
, Tronnier, Michael (Author)
, Hein, Rüdiger (Author)
, Schuler, Gerold (Author)
, Egberts, Friederike (Author)
, Garbe, Claus (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource